查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018942

白色生物技術市場：2026-2032年全球市場預測（依產品類型、原料來源、生物類型、產品形態、技術、生產規模及最終用途分類）

White Biotechnology Market by Product Type, Feedstock Source, Organism Type, Product Form, Technology, Production Scale, End-Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，白色生物技術市場價值將達到 3,202.2 億美元，到 2026 年將成長至 3,467.3 億美元，到 2032 年將達到 5,673.6 億美元，複合年成長率為 8.51%。

主要市場統計數據
基準年 2025 3202.2億美元
預計年份：2026年 3467.3億美元
預測年份：2032年 5673.6億美元
複合年成長率 (%) 8.51%

對不斷發展的白色生物技術趨勢進行了簡潔扼要而又全面的概述，涵蓋了技術進步、不斷變化的監管環境和戰略挑戰。

白色生物技術領域正處於一個轉折點，創新、永續性和不斷變化的監管環境在此交匯，重塑著該產業的價值鏈。本書總結了影響生物製程和生物基產品在不同產業中開發、生產和商業化方式的許多因素。隨著相關人員日益重視低碳解決方案和循環經濟，發酵、酵素催化和基因工程等技術的應用範圍正從利基領域擴展到主流製造策略。

分子層次的創新、製程的密集化以及對永續性的需求，是如何重塑白色生物技術領域的產業價值鍊和商業性重點的？

白色生物技術正經歷一場變革，其驅動力來自分子生物學的快速發展、製程密度的不斷提高以及對永續性的需求，這些因素正在改變各個工業領域的優先事項。合成生物學和CRISPR基因編輯技術正在加速客製化微生物和酵素的開發，從而拓展可生產的生化產品範圍，並實現資源高效的生產管道。因此，企業正日益尋求整合的生物製程平台，將上游發酵、精準的酵素催化和精簡的下游製程相結合，以縮短開發週期並提高單位產品的經濟效益。

美國關稅調整的連鎖反應正在重建白色生物技術領域的籌資策略、生產基地和供應鏈的韌性。

美國關稅政策的決定為白人生物技術生態系統中的生產商、供應商和買家帶來了新的商業性複雜性。到2025年，這些政策的累積影響將反映在進口成本、供應鏈籌資策略和價格趨勢的調整上，迫使企業重新評估其採購和製造地。為了因應某些生物基原料和半成品關稅的提高，一些公司正在加快本地化生產，將關鍵加工流程遷回國內，或探索替代原料來源，以減少對高關稅商品的依賴。

細分市場洞察揭示了產品類型、加工技術、應用、最終用戶和原料選擇如何塑造獨特的策略路徑。

深入的市場細分揭示了每種產品類型、技術、應用、最終用戶和原料選擇的不同機會領域，從而影響研發重點和商業性策略。產品層面的細分涵蓋胺基酸、生質燃料、生物製藥、生質塑膠、酵素和維生素，以及L-離胺酸和L-蘇氨酸、生物柴油和生質乙醇、單株抗體和重組蛋白、PHA和PLA生質塑膠、工業和特種酵素以及維生素C和E等子類別，每個類別都具有獨特的技術和監管考量。這種產品多樣性影響著下游製程的複雜性、監管管道以及客戶接受產品的時間節點。

對全球各地白人生物技術策略的影響因素——採用模式、法規環境和業務重點——進行跨區域的概述。

區域趨勢顯示，美洲、歐洲、中東和非洲以及亞太地區的技術採納、產能和政策環境呈現不同的發展軌跡，每個地區都展現出獨特的商業性特徵和營運考量。在美洲，下游製程創新、創業投資活動和強勁的機構投資者需求等優勢，與該地區特有的原料依賴性和對貿易政策的敏感性形成鮮明對比，而這些因素都會影響採購決策。這些趨勢有利於那些能夠將技術差異化與敏捷的供應鏈結構結合的公司。

成熟企業與創新者之間的競爭、夥伴關係與卓越營運如何塑造白色生物技術領域的領導地位？

白色生物技術領域的企業格局由成熟的工業參與企業、專業的生物程序創新者和敏捷的Start-Ups組成，這三者共同造就了激烈的競爭和合作機會。成熟的化工和農業公司正利用其下游管道和規模優勢整合生物基產品線，而專業的生物技術公司則專注於酶工程、細胞培養最佳化和新型發酵管道等平台能力，以搶佔細分市場。這種兩極化促使各公司尋求互補能力，從而促進策略夥伴關係、授權授權和定向收購。

經營團隊可以採取切實可行的、高優先級的行動，以降低商業化風險、最佳化營運並加速採用生物基工業解決方案。

產業領導者應採取務實的措施，將科學研究潛力轉化為永續的商業性成果，同時管控監管、供應鏈和政策風險。首先，他們應優先考慮模組化和靈活的生產設計，以便快速調整原料投入和產品線，從而降低關稅和原料價格波動風險。其次，他們應投資於製程整合和下游加工能力，以降低單位成本和環境影響，使生物基替代品在經濟和環境方面都對終端用戶更具吸引力。

採用嚴謹的混合方法研究途徑，結合與專家的直接訪談、技術文獻綜述和檢驗，以檢驗策略見解。

本研究結合專家訪談、技術文獻綜述和跨領域檢驗驗證，整合了一手和二手研究方法，從而對白色生物技術領域的發展趨勢提供了可靠且經過驗證的檢驗。一手資料包括對研發負責人、製程工程師、採購經理和監管專家的結構化訪談。這些訪談提供了關於技術成熟度、供應鏈限制因素和客戶採納促進因素的定性見解。除這些訪談外，還進行了實地考察和檢驗研討會，以確保對技術細節的解讀與實際應用相符。

整合技術、監管和營運因素，得出實現白色生物技術創新商業化的關鍵策略結論。

這個結論總結了決策者在應對不斷變化的白色生物技術格局時需要關注的核心要點：技術效率的提升、監管和永續性促進因素以及外部政策共同決定了哪些提案能夠成功推廣。那些兼具卓越技術、靈活製造地和完善的永續發展理念的企業，最有可能實現永續價值。此外，為了因應關稅趨勢和區域政策差異，企業還需要具備策略柔軟性和積極主動的供應鏈管理能力，以保持競爭力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 白色生物技術市場：依產品類型分類

  • 工業酵素
    • 碳水化合物消化酶
    • 蛋白酶
    • 脂肪酶
    • 氧化還原酶
  • 生化產品
    • 有機酸
    • 酒精飲料
    • 胺基酸
    • 生物表面活性劑
  • 生質燃料和生質能源
    • 生質乙醇
    • 生物丁醇
    • 沼氣和生物甲烷
  • 生物聚合物
    • PLA
    • PHA
    • PBS
    • 澱粉混合物

第9章 白色生物技術市場：依原料來源分類

  • 糖和澱粉
    • 玉米
    • 甘蔗
  • 木質纖維素生質能
    • 農業殘餘物
    • 林業剩餘物
    • 能源作物
  • 油脂
    • 植物油
    • 甘油
  • C1 和氣態原料
    • CO2
    • 合成氣
    • 甲烷
  • 廢棄物和副產品
    • 乳清
    • 糖蜜
    • 食物廢棄物
  • 藻類和海洋生質能
    • 微藻類
    • 海藻

第10章 白色生物技術市場：依生物類型分類

  • 細菌
    • 大腸桿菌
    • 芽孢桿菌屬
    • 棒狀桿菌屬
  • 酵母菌
    • 釀酒酵母
    • 科馬加塔埃拉·法菲伊
  • 絲狀真菌
    • 麴菌屬
    • 里氏木黴
  • 微藻類和藍菌
    • 小球藻屬
    • 螺旋藻（Altrospira）
  • 古菌

第11章 白色生物技術市場：依產品類型分類

  • 液體
  • 粉末
  • 固定的

第12章 白色生物技術市場：依技術分類

  • 下游製程技術
    • 細胞分離
    • 一級純化
    • 純化
    • 配方
    • 公共產業與回收利用
  • 發酵技術
    • 浸沒式發酵
    • 固相發酵
    • 氣體發酵
  • 全細胞生物催化劑
  • 基因工程與合成生物學

第13章 白色生物技術市場：依生產規模分類

  • 實驗室
  • 飛行員
  • 示範
  • 商業的

第14章 白色生物技術市場：依最終用途分類

  • 飲食
    • 麵包製作
    • 乳製品
    • 釀造和蒸餾
    • 果汁和飲料
  • 清潔劑和清潔劑
    • 洗衣店
    • 洗碗
  • 動物飼料
    • 家禽
    • 反芻動物
  • 紙漿和造紙
    • 漂
    • 脫墨
  • 紡織品和皮革
    • 脫膠
    • 生物拋光
  • 化學塑膠
    • 單體和中間體
    • 生質塑膠
  • 能源與公共產業
    • 乙醇廠
    • 沼氣廠
  • 個人護理和化妝品
    • 護膚
    • 護髮

第15章 白色生物技術市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 白色生技市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 白色生物技術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國白色生物技術市場

第19章：中國的白色生物技術市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AB Enzymes GmbH
  • Archer Daniels Midland Company
  • Arzeda, Inc.
  • Avantium NV
  • BASF SE
  • Biocon Limited
  • Biomason, Inc.
  • Braskem SA
  • Buhler AG
  • Cargill, Incorporated
  • Clariant AG
  • Corbion NV
  • Covestro AG
  • DSM-Firmenich AG
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Genomatica, Inc.
  • Gevo, Inc.
  • Ginkgo Bioworks Holdings, Inc.
  • Ginkgo Bioworks Holdings, Inc.
  • Ingredion Incorporated
  • International Flavors & Fragrances Inc.
  • Jeneil BIoTech Inc.
  • Johnson Matthey plc
  • LanzaTech, Inc.
  • Lonza Group AG
  • NatureWorks LLC by PTT Global Chemical
  • Novonesis Group
  • Solugen, Inc.
  • Tate & Lyle PLC
Product Code: MRR-710B1F0AC6A9

The White Biotechnology Market was valued at USD 320.22 billion in 2025 and is projected to grow to USD 346.73 billion in 2026, with a CAGR of 8.51%, reaching USD 567.36 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 320.22 billion
Estimated Year [2026] USD 346.73 billion
Forecast Year [2032] USD 567.36 billion
CAGR (%) 8.51%

A concise yet comprehensive orientation to the evolving white biotechnology landscape that frames technical progress, regulatory shifts, and strategic imperatives

The white biotechnology sector is at an inflection point where innovation, sustainability, and evolving regulation intersect to reshape industrial value chains. This introduction synthesizes the forces that are redefining how biological processes and bio-based products are developed, produced, and commercialized across diverse industries. As industrial stakeholders increasingly prioritize low-carbon solutions and circularity, the role of fermentation, enzyme catalysis, and genetic engineering has expanded beyond niche applications into mainstream manufacturing strategies.

Throughout this summary, attention is placed on both technological advances and shifting market dynamics that influence decision-making for manufacturers, processors, and end users. Advances in cell culture and enzyme technology are improving process yields and enabling new product classes, while downstream processing innovations lower purification costs and reduce environmental footprints. Concurrently, regulatory frameworks and public procurement preferences are elevating sustainability credentials as a competitive differentiator.

The introduction sets the stage for deeper analysis by outlining the key themes that follow: transformative shifts in technology and policy, the implications of tariff actions, segmentation-driven insights across product and application categories, regional performance nuances, and practical recommendations for leaders seeking to convert scientific capability into commercial advantage.

How molecular innovations, process intensification, and sustainability imperatives are reorganizing industrial value chains and commercial priorities in white biotechnology

White biotechnology is undergoing transformative shifts driven by rapid advances in molecular biology, process intensification, and sustainability mandates that are altering industrial priorities across multiple sectors. Synthetic biology and CRISPR-enabled engineering are accelerating the development of bespoke microbes and enzymes, thereby expanding the palette of producible biochemicals and enabling resource-efficient pathways. As a result, companies are increasingly pursuing integrated bioprocess platforms that combine upstream fermentation, precision enzyme catalysis, and streamlined downstream processing to shorten development cycles and improve unit economics.

Concurrently, demand-side shifts are elevating biologically derived products in food, materials, and pharmaceuticals. Buyers are placing higher value on traceability, lower lifecycle emissions, and functional performance that matches or exceeds conventional alternatives. These expectations are catalyzing cross-sector partnerships between ingredient producers, formulators, and brand owners seeking to co-develop applications that can scale commercially. In addition, capital allocation patterns are tilting toward firms that demonstrate both technological differentiation and clear pathways to regulatory compliance, prompting consolidation and strategic alliances.

Taken together, these transformative shifts are converting laboratory breakthroughs into industrial options at pace, necessitating adaptive strategies that reconcile scientific potential with supply chain resilience and regulatory realities.

The ripple effects of United States tariff adjustments reshaping sourcing strategies, production footprints, and supply chain resilience in white biotechnology

Tariff policy decisions in the United States have introduced a new layer of commercial complexity for producers, suppliers, and buyers in the white biotechnology ecosystem. The cumulative impacts observed in 2025 reflect adjustments across import costs, supply chain sourcing strategies, and pricing dynamics that require enterprises to revisit procurement and manufacturing footprints. Higher duties on select bio-derived inputs and intermediate goods have prompted some firms to accelerate local production initiatives, repatriate critical processing steps, or seek alternative feedstock routes that reduce exposure to tariffed commodities.

As a consequence, companies with flexible process designs and modular manufacturing capabilities have been better positioned to mitigate added cost pressures through rapid reconfiguration of ingredient sourcing. Downstream processors and contract development and manufacturing organizations have seen an increased demand for localization services as clients prioritize tariff risk mitigation and continuity of supply. In parallel, purchasers have intensified supplier qualification criteria to incorporate tariff sensitivity analysis, total landed cost assessments, and contingency sourcing plans.

Importantly, the tariff-driven rebalancing has also amplified interest in vertical integration for actors that can secure feedstock availability and control conversion steps. Firms are therefore evaluating strategic investments that promote raw material resilience, reduce logistics exposure, and preserve margins while maintaining compliance with evolving trade and customs regimes.

Segment-specific intelligence revealing how product categories, processing technologies, applications, end users, and feedstock choices create distinct strategic pathways

Insightful segmentation reveals differentiated opportunity zones across product types, technologies, applications, end users, and feedstock choices that influence both R&D priorities and commercial approaches. Product-level distinctions span amino acids, biofuels, biopharmaceuticals, bioplastics, enzymes, and vitamins, with subcategories such as L-Lysine and L-Threonine, biodiesel and bioethanol, monoclonal antibodies and recombinant proteins, PHA and PLA bioplastics, industrial versus specialty enzymes, and vitamin C and vitamin E each presenting unique technical and regulatory considerations. These product variances shape downstream processing complexity, regulatory pathways, and customer adoption timelines.

On the technology axis, differentiation emerges between cell culture platforms, downstream separation science, enzyme engineering and immobilization, fermentation modalities, and genetic engineering approaches including CRISPR and recombinant DNA techniques. Each technological domain offers distinct levers for cost reduction, yield enhancement, and functionality expansion, and firms often combine multiple technologies to create competitive barriers. Application-driven segmentation covers food and beverages, household care and industrial cleaning, oil and gas interventions, paper and pulp treatments, and textiles and leather processing, where use-case specificity defines formulation requirements and performance benchmarks.

End-user distinctions among agriculture, animal feed, chemical manufacturing, cosmetics, and pharmaceuticals further refine commercialization strategies, as customers in each sector prioritize different attributes-such as shelf stability for cosmetics, regulatory dossiers for pharmaceuticals, or nutrient density for animal feed. Finally, feedstock selection among cassava, corn, sugarcane, and wheat influences sustainability narratives, supply chain risk profiles, and cost structures, underscoring the need for integrated product-to-feedstock planning that aligns technical feasibility with commercial demand.

A cross-regional synthesis of adoption patterns, regulatory environments, and operational priorities that govern white biotechnology strategies across global hubs

Regional dynamics demonstrate varied trajectories for adoption, production capacity, and policy environment across the Americas, Europe, Middle East & Africa, and Asia-Pacific, with each geography presenting distinct commercial contours and operational considerations. In the Americas, strengths in downstream processing innovation, venture capital activity, and strong institutional demand are contrasted with localized feedstock dependencies and trade policy sensitivities that shape sourcing decisions. These dynamics favor firms that can combine technical differentiation with agile supply chain configurations.

The Europe, Middle East & Africa region emphasizes regulatory rigor, sustainability reporting, and circular economy policies that create opportunities for bio-based materials and greener manufacturing processes. Producers and technology suppliers operating in this region must navigate harmonized regulatory frameworks and growing customer demand for transparency, which rewards firms that can demonstrate verifiable lifecycle improvements and compliance readiness. In contrast, the Asia-Pacific region is characterized by scale-driven manufacturing capabilities, rapidly expanding domestic demand for bio-derived ingredients, and diverse feedstock availability, encouraging investments in large-scale fermentation infrastructure and regional partnerships to meet both domestic and export-oriented needs.

Taken together, these regional contrasts indicate that successful actors tailor their market entry and growth strategies to local regulatory expectations, feedstock ecosystems, and customer priorities while retaining the flexibility to redeploy capabilities across geographies as commercial conditions evolve.

How competitive dynamics, partnerships, and operational excellence among incumbents and innovators are shaping leadership in white biotechnology

Company-level dynamics in white biotechnology emphasize a mix of incumbent industrial players, specialized bioprocess innovators, and agile start-ups that together define competitive intensity and collaboration opportunities. Established chemical and agricultural firms are leveraging their downstream channels and scale to integrate bio-based product lines, while specialist biotechnology companies concentrate on platform capabilities such as enzyme engineering, cell culture optimization, and novel fermentation pathways to capture niche value pools. This duality has encouraged strategic partnerships, licensing arrangements, and targeted acquisitions as firms seek complementary capabilities.

In addition, the investment landscape continues to support companies that demonstrate reproducible process performance and clear regulatory strategies. Strategic differentiation frequently arises from proprietary process know-how, robust intellectual property portfolios, and demonstrated supply chain partnerships that de-risk commercialization for large buyers. Contract development and manufacturing organizations are increasingly relevant as intermediaries that enable smaller innovators to scale without requiring heavy capital outlays.

Operational excellence, quality systems alignment with regulatory standards, and the ability to articulate verifiable sustainability metrics are common success factors among leading companies. Firms that combine technical depth with strong commercialization pathways and responsive customer engagement tend to outperform peers in attracting strategic partners and long-term off-take agreements.

Practical and prioritized actions that leadership teams can implement to de-risk commercialization, optimize operations, and accelerate adoption of bio-based industrial solutions

Industry leaders should adopt a pragmatic suite of actions to translate scientific potential into durable commercial outcomes while managing regulatory, supply chain, and policy risks. First, prioritize modular and flexible manufacturing designs that allow rapid adaptation of feedstock inputs and product lines to mitigate tariff exposure and feedstock volatility. Second, invest in process intensification and downstream processing capabilities to reduce unit costs and environmental impact, thereby making bio-based alternatives economically and ecologically compelling for end users.

Third, develop targeted partnerships across the value chain, including feedstock suppliers, contract manufacturers, and brand owners, to accelerate market access and share the capital burden of scale-up. Fourth, integrate regulatory and sustainability criteria into product development roadmaps from day one to shorten approval times and meet buyer expectations for transparent environmental performance. Additionally, strengthen intellectual property strategies that protect process innovations while enabling selective licensing where complementary partners can accelerate adoption.

Finally, embed advanced analytics and scenario planning into strategic decision-making so that leadership teams can stress-test supply chains, evaluate tariff scenarios, and identify priority markets for localized investment. By combining operational flexibility, collaborative commercialization models, and disciplined regulatory planning, companies can convert promising technologies into repeatable, profitable product lines.

A rigorous mixed-methods research approach integrating primary expert engagement, technical literature review, and triangulation to validate strategic insights

This research synthesizes primary and secondary methods to deliver a robust and validated perspective on white biotechnology dynamics, combining expert interviews, technical literature review, and cross-sector triangulation. Primary inputs include structured interviews with R&D leaders, process engineers, procurement heads, and regulatory specialists who provided qualitative insights into technology maturation, supply chain constraints, and customer adoption drivers. These conversations were complemented by site visit observations and validation workshops that ensured interpretation of technical details aligned with real-world practice.

Secondary research encompassed peer-reviewed journals, industry standards guidance, patent filings, and publicly available regulatory documentation to ensure technical assertions and policy interpretations were grounded in verifiable sources. Data triangulation techniques were applied to reconcile differing inputs and to surface consistent patterns across product segments and geographies. Quality assurance steps included independent expert review and iterative cross-checking of thematic conclusions to reduce bias and strengthen reproducibility.

Ethical considerations and transparency guided the methodology, with confidential inputs anonymized and proprietary information handled under agreed non-disclosure terms. This mixed-methods approach provides leaders with a defensible evidence base for strategic planning and operational prioritization in white biotechnology.

Key strategic conclusions that synthesize technological, regulatory, and operational levers critical for commercializing white biotechnology innovations

The conclusion encapsulates the central takeaways for decision-makers navigating the evolving white biotechnology landscape: technology-enabled efficiency gains, regulatory and sustainability drivers, and external policy actions collectively determine which propositions will scale successfully. Organizations that combine technical excellence with adaptive manufacturing footprints and integrated sustainability narratives are best positioned to capture enduring value. Moreover, tariff developments and regional policy differences require strategic flexibility and proactive supply chain management to preserve competitiveness.

Looking ahead, success will hinge on the ability to align product development with customer-specific performance metrics, to secure reliable feedstock channels, and to demonstrate credible lifecycle benefits that resonate with regulators and purchasers alike. Strategic collaborations, selective vertical integration, and disciplined intellectual property management will be powerful tools for firms seeking to bridge technical demonstration and commercial adoption. Ultimately, stakeholders who treat biological innovation as part of a broader systems transformation-incorporating procurement, regulatory strategy, and customer engagement-will accelerate adoption and create more resilient business models.

This synthesis should help leadership teams prioritize investments, structure partnerships, and design operational roadmaps that convert scientific capability into scalable, sustainable commercial outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. White Biotechnology Market, by Product Type

  • 8.1. Industrial Enzymes
    • 8.1.1. Carbohydrases
    • 8.1.2. Proteases
    • 8.1.3. Lipases
    • 8.1.4. Oxidoreductases
  • 8.2. Biochemicals
    • 8.2.1. Organic Acids
    • 8.2.2. Alcohols
    • 8.2.3. Amino Acids
    • 8.2.4. Biosurfactants
  • 8.3. Biofuels & Bioenergy
    • 8.3.1. Bioethanol
    • 8.3.2. Biobutanol
    • 8.3.3. Biogas & Biomethane
  • 8.4. Biopolymers
    • 8.4.1. PLA
    • 8.4.2. PHA
    • 8.4.3. PBS
    • 8.4.4. Starch Blends

9. White Biotechnology Market, by Feedstock Source

  • 9.1. Sugars & Starches
    • 9.1.1. Corn
    • 9.1.2. Sugarcane
  • 9.2. Lignocellulosic Biomass
    • 9.2.1. Agricultural Residues
    • 9.2.2. Forestry Residues
    • 9.2.3. Energy Crops
  • 9.3. Oils & Fats
    • 9.3.1. Vegetable Oils
    • 9.3.2. Glycerol
  • 9.4. C1 & Gas Substrates
    • 9.4.1. CO2
    • 9.4.2. Syngas
    • 9.4.3. Methane
  • 9.5. Waste & Side Streams
    • 9.5.1. Dairy Whey
    • 9.5.2. Molasses
    • 9.5.3. Food Waste
  • 9.6. Algal & Marine Biomass
    • 9.6.1. Microalgae
    • 9.6.2. Seaweed

10. White Biotechnology Market, by Organism Type

  • 10.1. Bacteria
    • 10.1.1. Escherichia coli
    • 10.1.2. Bacillus spp.
    • 10.1.3. Corynebacterium spp.
  • 10.2. Yeasts
    • 10.2.1. Saccharomyces cerevisiae
    • 10.2.2. Komagataella phaffii
  • 10.3. Filamentous Fungi
    • 10.3.1. Aspergillus spp.
    • 10.3.2. Trichoderma reesei
  • 10.4. Microalgae & Cyanobacteria
    • 10.4.1. Chlorella spp.
    • 10.4.2. Arthrospira (Spirulina)
  • 10.5. Archaea

11. White Biotechnology Market, by Product Form

  • 11.1. Liquid
  • 11.2. Powder
  • 11.3. Immobilized

12. White Biotechnology Market, by Technology

  • 12.1. Downstream Technology
    • 12.1.1. Cell Separation
    • 12.1.2. Primary Purification
    • 12.1.3. Polishing
    • 12.1.4. Formulation
    • 12.1.5. Utilities & Recovery
  • 12.2. Fermentation Technology
    • 12.2.1. Submerged Fermentation
    • 12.2.2. Solid-State Fermentation
    • 12.2.3. Gas Fermentation
  • 12.3. Whole-Cell Biocatalysis
  • 12.4. Genetic Engineering & Synthetic Biology

13. White Biotechnology Market, by Production Scale

  • 13.1. Lab
  • 13.2. Pilot
  • 13.3. Demonstration
  • 13.4. Commercial

14. White Biotechnology Market, by End-Use

  • 14.1. Food & Beverage
    • 14.1.1. Baking
    • 14.1.2. Dairy
    • 14.1.3. Brewing & Distilling
    • 14.1.4. Juices & Beverages
  • 14.2. Detergents & Cleaning
    • 14.2.1. Laundry
    • 14.2.2. Dishwashing
  • 14.3. Animal Nutrition
    • 14.3.1. Poultry
    • 14.3.2. Ruminants
  • 14.4. Pulp & Paper
    • 14.4.1. Bleaching
    • 14.4.2. Deinking
  • 14.5. Textiles & Leather
    • 14.5.1. Desizing
    • 14.5.2. Bio-Polishing
  • 14.6. Chemicals & Plastics
    • 14.6.1. Monomers & Intermediates
    • 14.6.2. Bioplastics
  • 14.7. Energy & Utilities
    • 14.7.1. Ethanol Plants
    • 14.7.2. Biogas Plants
  • 14.8. Personal Care & Cosmetics
    • 14.8.1. Skin Care
    • 14.8.2. Hair Care

15. White Biotechnology Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. White Biotechnology Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. White Biotechnology Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States White Biotechnology Market

19. China White Biotechnology Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. AB Enzymes GmbH
  • 20.6. Archer Daniels Midland Company
  • 20.7. Arzeda, Inc.
  • 20.8. Avantium N.V.
  • 20.9. BASF SE
  • 20.10. Biocon Limited
  • 20.11. Biomason, Inc.
  • 20.12. Braskem S.A.
  • 20.13. Buhler AG
  • 20.14. Cargill, Incorporated
  • 20.15. Clariant AG
  • 20.16. Corbion N.V.
  • 20.17. Covestro AG
  • 20.18. DSM-Firmenich AG
  • 20.19. DuPont de Nemours, Inc.
  • 20.20. Evonik Industries AG
  • 20.21. Genomatica, Inc.
  • 20.22. Gevo, Inc.
  • 20.23. Ginkgo Bioworks Holdings, Inc.
  • 20.24. Ginkgo Bioworks Holdings, Inc.
  • 20.25. Ingredion Incorporated
  • 20.26. International Flavors & Fragrances Inc.
  • 20.27. Jeneil Biotech Inc.
  • 20.28. Johnson Matthey plc
  • 20.29. LanzaTech, Inc.
  • 20.30. Lonza Group AG
  • 20.31. NatureWorks LLC by PTT Global Chemical
  • 20.32. Novonesis Group
  • 20.33. Solugen, Inc.
  • 20.34. Tate & Lyle PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL WHITE BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL WHITE BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FEEDSTOCK SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ORGANISM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCTION SCALE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY END-USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES WHITE BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA WHITE BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CARBOHYDRASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CARBOHYDRASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CARBOHYDRASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIPASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIPASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIPASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OXIDOREDUCTASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OXIDOREDUCTASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OXIDOREDUCTASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOCHEMICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOCHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOCHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ORGANIC ACIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ORGANIC ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALCOHOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALCOHOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALCOHOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOSURFACTANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOSURFACTANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOSURFACTANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS & BIOENERGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS & BIOENERGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS & BIOENERGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS & BIOENERGY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOETHANOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOETHANOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOETHANOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOBUTANOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOBUTANOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOBUTANOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS & BIOMETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS & BIOMETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS & BIOMETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPOLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPOLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPOLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPOLYMERS, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PLA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PLA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PLA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PHA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PHA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PHA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PBS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PBS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PBS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY STARCH BLENDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY STARCH BLENDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY STARCH BLENDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FEEDSTOCK SOURCE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARS & STARCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARS & STARCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARS & STARCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARS & STARCHES, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CORN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CORN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CORN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARCANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARCANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUGARCANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIGNOCELLULOSIC BIOMASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIGNOCELLULOSIC BIOMASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIGNOCELLULOSIC BIOMASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIGNOCELLULOSIC BIOMASS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL RESIDUES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL RESIDUES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL RESIDUES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FORESTRY RESIDUES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FORESTRY RESIDUES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FORESTRY RESIDUES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY CROPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY CROPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY CROPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OILS & FATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OILS & FATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OILS & FATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OILS & FATS, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VEGETABLE OILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VEGETABLE OILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VEGETABLE OILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GLYCEROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GLYCEROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GLYCEROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY C1 & GAS SUBSTRATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY C1 & GAS SUBSTRATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY C1 & GAS SUBSTRATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY C1 & GAS SUBSTRATES, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CO2, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CO2, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CO2, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SYNGAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SYNGAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SYNGAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY METHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY METHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY METHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WASTE & SIDE STREAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WASTE & SIDE STREAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WASTE & SIDE STREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WASTE & SIDE STREAMS, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY WHEY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY WHEY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY WHEY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MOLASSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MOLASSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MOLASSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD WASTE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD WASTE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD WASTE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALGAL & MARINE BIOMASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALGAL & MARINE BIOMASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALGAL & MARINE BIOMASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ALGAL & MARINE BIOMASS, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SEAWEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SEAWEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SEAWEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ESCHERICHIA COLI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ESCHERICHIA COLI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACILLUS SPP., BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACILLUS SPP., BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BACILLUS SPP., BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CORYNEBACTERIUM SPP., BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CORYNEBACTERIUM SPP., BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CORYNEBACTERIUM SPP., BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY YEASTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY YEASTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY YEASTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY YEASTS, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY KOMAGATAELLA PHAFFII, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY KOMAGATAELLA PHAFFII, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY KOMAGATAELLA PHAFFII, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILAMENTOUS FUNGI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILAMENTOUS FUNGI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILAMENTOUS FUNGI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILAMENTOUS FUNGI, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ASPERGILLUS SPP., BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ASPERGILLUS SPP., BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ASPERGILLUS SPP., BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TRICHODERMA REESEI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TRICHODERMA REESEI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TRICHODERMA REESEI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE & CYANOBACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE & CYANOBACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE & CYANOBACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROALGAE & CYANOBACTERIA, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHLORELLA SPP., BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHLORELLA SPP., BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHLORELLA SPP., BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ARTHROSPIRA (SPIRULINA), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ARTHROSPIRA (SPIRULINA), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ARTHROSPIRA (SPIRULINA), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ARCHAEA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ARCHAEA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ARCHAEA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY IMMOBILIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY IMMOBILIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY IMMOBILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRIMARY PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRIMARY PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRIMARY PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POLISHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POLISHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POLISHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FORMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FORMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FORMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY UTILITIES & RECOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY UTILITIES & RECOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY UTILITIES & RECOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SOLID-STATE FERMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SOLID-STATE FERMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SOLID-STATE FERMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GAS FERMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GAS FERMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GAS FERMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WHOLE-CELL BIOCATALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WHOLE-CELL BIOCATALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY WHOLE-CELL BIOCATALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING & SYNTHETIC BIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING & SYNTHETIC BIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING & SYNTHETIC BIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PILOT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PILOT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PILOT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DEMONSTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DEMONSTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DEMONSTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BAKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BAKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BAKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 253. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BREWING & DISTILLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BREWING & DISTILLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BREWING & DISTILLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY JUICES & BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY JUICES & BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 259. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY JUICES & BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS & CLEANING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS & CLEANING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 262. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS & CLEANING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS & CLEANING, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LAUNDRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 265. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LAUNDRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 266. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY LAUNDRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DISHWASHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 268. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DISHWASHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DISHWASHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 271. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 274. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 275. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 278. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RUMINANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RUMINANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PULP & PAPER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 281. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PULP & PAPER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 282. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PULP & PAPER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PULP & PAPER, 2018-2032 (USD MILLION)
  • TABLE 284. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BLEACHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BLEACHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 286. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BLEACHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 287. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DEINKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 288. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DEINKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 289. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DEINKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 290. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TEXTILES & LEATHER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 291. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TEXTILES & LEATHER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 292. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TEXTILES & LEATHER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 293. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TEXTILES & LEATHER, 2018-2032 (USD MILLION)
  • TABLE 294. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DESIZING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 295. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DESIZING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 296. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DESIZING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 297. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIO-POLISHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 298. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIO-POLISHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 299. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIO-POLISHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 300. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHEMICALS & PLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 301. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHEMICALS & PLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 302. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHEMICALS & PLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 303. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHEMICALS & PLASTICS, 2018-2032 (USD MILLION)
  • TABLE 304. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MONOMERS & INTERMEDIATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 305. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MONOMERS & INTERMEDIATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 306. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MONOMERS & INTERMEDIATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 307. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 308. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 309. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 310. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY & UTILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 311. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY & UTILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 312. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY & UTILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 313. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENERGY & UTILITIES, 2018-2032 (USD MILLION)
  • TABLE 314. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ETHANOL PLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 315. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ETHANOL PLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 316. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ETHANOL PLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 317. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS PLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 318. GLOBAL WHITE